These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 22796735

  • 1. Prostatic calculi influence the antimicrobial efficacy in men with chronic bacterial prostatitis.
    Zhao WP, Li YT, Chen J, Zhang ZG, Jiang H, Xia D, Wang S, Wang P.
    Asian J Androl; 2012 Sep; 14(5):715-9. PubMed ID: 22796735
    [Abstract] [Full Text] [Related]

  • 2. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience.
    Shoskes DA, Thomas KD, Gomez E.
    J Urol; 2005 Feb; 173(2):474-7. PubMed ID: 15643213
    [Abstract] [Full Text] [Related]

  • 3. Prostatic calcifications are associated with a more severe symptom burden in men with type II chronic bacterial prostatitis.
    Stamatiou K, Magri V, Perletti G, Trinchieri A, Lacroix R, Rekleiti N, Moschouris H.
    Arch Ital Urol Androl; 2019 Jul 02; 91(2):. PubMed ID: 31266275
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial therapy for chronic bacterial prostatitis.
    Perletti G, Marras E, Wagenlehner FM, Magri V.
    Cochrane Database Syst Rev; 2013 Aug 12; 2013(8):CD009071. PubMed ID: 23934982
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Etiotropic therapy of chronic bacterial prostatitis].
    Popov SV, Mazo EB.
    Urologiia; 2008 Aug 12; (3):36, 38-41. PubMed ID: 18669346
    [Abstract] [Full Text] [Related]

  • 8. Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study.
    Magri V, Perletti G, Cai T, Stamatiou K, Trinchieri A, Montanari E.
    Chemotherapy; 2019 Aug 12; 64(1):8-16. PubMed ID: 31112957
    [Abstract] [Full Text] [Related]

  • 9. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
    Abdel-Meguid TA, Mosli HA, Farsi H, Alsayyad A, Tayib A, Sait M, Abdelsalam A.
    Can J Urol; 2018 Apr 12; 25(2):9273-9280. PubMed ID: 29680006
    [Abstract] [Full Text] [Related]

  • 10. Identification, pharmacologic considerations, and management of prostatitis.
    Schiller DS, Parikh A.
    Am J Geriatr Pharmacother; 2011 Feb 12; 9(1):37-48. PubMed ID: 21459307
    [Abstract] [Full Text] [Related]

  • 11. Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
    Cai T, Tiscione D, Gallelli L, Verze P, Palmieri A, Mirone V, Bartoletti R, Malossini G.
    Arch Ital Urol Androl; 2016 Oct 05; 88(3):177-182. PubMed ID: 27711089
    [Abstract] [Full Text] [Related]

  • 12. [A Japanese version of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI, Okayama version) and the clinical evaluation of cernitin pollen extract for chronic non-bacterial prostatitis].
    Monden K, Tsugawa M, Ninomiya Y, Ando E, Kumon H.
    Nihon Hinyokika Gakkai Zasshi; 2002 May 05; 93(4):539-47. PubMed ID: 12056038
    [Abstract] [Full Text] [Related]

  • 13. Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study.
    Cai T, Tamanini I, Mattevi D, Verze P, Palmieri A, Malossini G, Mirone V, Novelli A, Tascini C, Johansen TEB.
    Int J Antimicrob Agents; 2020 Jul 05; 56(1):105935. PubMed ID: 32156620
    [Abstract] [Full Text] [Related]

  • 14. Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients.
    Vicari LO, Castiglione R, Salemi M, Vicari BO, Mazzarino MC, Vicari E.
    Andrologia; 2016 May 05; 48(4):380-8. PubMed ID: 26259725
    [Abstract] [Full Text] [Related]

  • 15. Multidisciplinary approach to prostatitis.
    Magri V, Boltri M, Cai T, Colombo R, Cuzzocrea S, De Visschere P, Giuberti R, Granatieri CM, Latino MA, Larganà G, Leli C, Maierna G, Marchese V, Massa E, Matteelli A, Montanari E, Morgia G, Naber KG, Papadouli V, Perletti G, Rekleiti N, Russo GI, Sensini A, Stamatiou K, Trinchieri A, Wagenlehner FME.
    Arch Ital Urol Androl; 2019 Jan 18; 90(4):227-248. PubMed ID: 30655633
    [Abstract] [Full Text] [Related]

  • 16. Antibiotic therapy of chronic bacterial prostatitis is more effective considering antibiotic susceptibility of all pathogens isolated.
    Kogan MI, Ibishev KS, Naboka YL, Gudima IA, Ferzauli AK, Ismailov RS, Naber KG.
    Investig Clin Urol; 2022 May 18; 63(3):325-333. PubMed ID: 35437957
    [Abstract] [Full Text] [Related]

  • 17. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A, Alas P, Nickel JC, Sarpola A, Helström PJ.
    Urology; 2003 Sep 18; 62(3):425-9. PubMed ID: 12946740
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of transrectal longitudinal ultrasonography of chronic non-bacterial prostatitis].
    Tanaka S, Yasumoto R, Asakawa M, Mori K, Kakinoki K, Maekawa M.
    Nihon Hinyokika Gakkai Zasshi; 1989 Jan 18; 80(1):35-8. PubMed ID: 2657157
    [Abstract] [Full Text] [Related]

  • 19. Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis.
    Weidner W, Ludwig M, Brähler E, Schiefer HG.
    Drugs; 1999 Jan 18; 58 Suppl 2():103-6. PubMed ID: 10553717
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.